Optimize 340B - ProxsysRx

ProxsysRx has generated over $135M in 340B revenue for the hospitals we serve.

And yes, we have a proven process for overcoming 340B ESP and manufacturer restrictions.
We only charge clients from the savings & revenue we generate for them, so there’s Zero Capital Risk.

What is your health system’s 340B ROI potential?
Use our online calculator for a preliminary estimate.

Recapture savings & revenue lost to 340B ESP and manufacturer restrictions.

Learn more about our unmatched program support.

And about our dedicated team’s continued success in overcoming manufacturer restrictions!

How do we do it?

Our proprietary software gives you a single access point for all of your 340B data.

ProxsysRx’s platform not only identifies current and past reimbursable prescriptions for you, it automatically applies for those reimbursements.

We know every prescription drug that’s 340B eligible — and we maintain a constantly-updated database that keeps you compliant at all times.

Why not plan a system demo and a free analysis of your 340B revenue potential today!

SCHEDULE NOW

Put ProxsysRx to work for your health system today.

If your hospital is 340B-eligible, you may be missing-out on millions of dollars in retail and specialty prescription reimbursements.

There are so many ways to overcome drug manufacturer restrictions and optimize 340B savings & revenue, while minimizing the likelihood of noncompliance.

Howard Hall. C: 205.588.0946 | howard.hall@proxsysrx.com

SCHEDULE NOW

ProxsysRx has generated over $135M in 340B revenue for the hospitals we serve.

Recapture savings & revenue lost to 340B ESP and manufacturer restrictions.

Our proprietary software gives you a single access point for all of your 340B data.